The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris ...

Retrieved on: 2021-07-29 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris .... View article details on hiswai:

Excerpt

Atreca Shares Slump On Cancer Drug Data. Atreca, Inc. (NASDAQ:BCEL) announced initial data from the dose escalation portion of its ongoing ...

Article found on: markets.businessinsider.com